1
Dinmohamed, Avinash G., Issa, Djamila E., van der Poel, Marjolein W. M., Schouten, Harry C., Lugtenburg, Pieternella J., Chamuleau, Martine E. D., Zweegman, Sonja, Visser, Otto
Veröffentlicht in: Dinmohamed , A G , Issa , D E , van der Poel , M W M , Schouten , H C , Lugtenburg , P J , Chamuleau , M E D , Zweegman , S & Visser , O 2017 , ' Treatment and relative survival in very elderly patients with DLBCL in The Netherlands : a population-based study, 1989 to 2015 ' , Blood , vol. 1 , no. 21 , pp. 1839-1841 . https://doi.org/10.1182/bloodadvances.2017011031 , https://doi.org/10.1182/bloodadvances.2017011031;
2017
Veröffentlicht in: Dinmohamed , A G , Issa , D E , van der Poel , M W M , Schouten , H C , Lugtenburg , P J , Chamuleau , M E D , Zweegman , S & Visser , O 2017 , ' Treatment and relative survival in very elderly patients with DLBCL in The Netherlands : a population-based study, 1989 to 2015 ' , Blood , vol. 1 , no. 21 , pp. 1839-1841 . https://doi.org/10.1182/bloodadvances.2017011031 , https://doi.org/10.1182/bloodadvances.2017011031;
2017
2
Pennings, Elise R.A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Issa, Djamila E., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Pennings , E R A , Durmaz , M , Visser , O , Posthuma , E F M , Issa , D E , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2024 , ' Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Blood Cancer Journal , vol. 14 , no. 1 , 3 . https://doi.org/10.1038/s41408-023-00970-z;
2024
Veröffentlicht in: Pennings , E R A , Durmaz , M , Visser , O , Posthuma , E F M , Issa , D E , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2024 , ' Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Blood Cancer Journal , vol. 14 , no. 1 , 3 . https://doi.org/10.1038/s41408-023-00970-z;
2024
3
4
Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M.A., Zijlstra, Josée M., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Durmaz , M , Visser , O , Posthuma , E F M , Brouwer , R E , Issa , D E , de Jong , D , Lam , K H , Blijlevens , N M A , Zijlstra , J M , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2022 , ' Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage : a nationwide, population-based study in the Netherlands, 1989–2018 ' , Blood Cancer Journal , vol. 12 , no. 3 , 38 . https://doi.org/10.1038/s41408-022-00637-1;
2022
Veröffentlicht in: Durmaz , M , Visser , O , Posthuma , E F M , Brouwer , R E , Issa , D E , de Jong , D , Lam , K H , Blijlevens , N M A , Zijlstra , J M , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2022 , ' Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage : a nationwide, population-based study in the Netherlands, 1989–2018 ' , Blood Cancer Journal , vol. 12 , no. 3 , 38 . https://doi.org/10.1038/s41408-022-00637-1;
2022
5
Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F. M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M. A., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Blood Cancer Journal ; volume 12, issue 3 ; ISSN 2044-5385;
2022
Veröffentlicht in: Blood Cancer Journal ; volume 12, issue 3 ; ISSN 2044-5385;
2022
6
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
7
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie Jose, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
8
Pennings, Elise R.A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Issa, Djamila E., Chamuleau, Martine E.D., Spanjaart, Anne M., van Meerten, Tom, Mutsaers, Pim G.N.J., Jak, Margot, van Dorp, Suzanne, Vermaat, Joost S.P., van der Poel, Marjolein W.M., Kuipers, Maria T., Thielen, Frederick W., Uyl-de Groot, Carin A., Lugtenburg, Pieternella J., José Kersten, Marie, Dinmohamed, Avinash G.
Veröffentlicht in: HemaSphere ; volume 7, issue S3, page e992046d ; ISSN 2572-9241;
2023
Veröffentlicht in: HemaSphere ; volume 7, issue S3, page e992046d ; ISSN 2572-9241;
2023
9
Spanjaart, Anne M., Pennings, Elise R.A., Mutsaers, Pim G.N.J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G.H., Kos, Milan, Vermaat, Joost S.P., Sijs-Szabo, Aniko, van der Poel, Marjolein W.M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I.M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023